SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Azora Therapeutics Reports 2026 Third Quarter Financial Results and Provides Business Update

Azora Therapeutics commenced trading on Nasdaq as “AZR”New executive team and Board of Directors appointedAT177 IND submission and Phase 1a initiation on track for the first half of 2027LOS ANGELES, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Azora Therapeutics, Inc. NASDAQ:AZR (“Azora” or the “Company”), a…

AZR

Related stories